2FME | pdb_00002fme

Crystal structure of the mitotic kinesin eg5 (ksp) in complex with mg-adp and (r)-4-(3-hydroxyphenyl)-n,n,7,8-tetramethyl-3,4-dihydroisoquinoline-2(1h)-carboxamide


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free: 
    0.305 (Depositor), 0.278 (DCC) 
  • R-Value Work: 
    0.280 (Depositor), 0.252 (DCC) 

Starting Model: other
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 2FME

Ligand Structure Quality Assessment 


This is version 1.5 of the entry. See complete history

Literature

Inhibitors of human mitotic kinesin Eg5: Characterization of the 4-phenyl-tetrahydroisoquinoline lead series

Tarby, C.M.Kaltenbach III, R.F.Huynh, T.Pudzianowski, A.Shen, H.Ortega-Nanos, M.Sheriff, S.Newitt, J.A.McDonnell, P.A.Burford, N.Fairchild, C.R.Vaccaro, W.Chen, Z.Borzilleri, R.M.Naglich, J.Lombardo, L.J.Gottardis, M.Trainor, G.L.Roussell, D.L.

(2006) Bioorg Med Chem Lett 16: 2095-2100

  • DOI: https://doi.org/10.1016/j.bmcl.2006.01.056
  • Primary Citation Related Structures: 
    2FME

  • PubMed Abstract: 

    In a high-throughput screening effort, a series of tetrahydroisoquinolines was identified as modest inhibitors of human Eg5. A medicinal chemistry optimization effort led to the identification of R-4-(3-hydroxyphenyl)-N,N-7,8-tetramethyl-3,4-dihydroisoquinoline-2(1H)-carboxamide (32a) as a potent inhibitor of human Eg5 (ATPase IC50 104 nM) with good anti-proliferative activity in A2780 cells (IC50 234 nM).


  • Organizational Affiliation
    • Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543, USA. christine.tarby@bms.com

Macromolecule Content 

  • Total Structure Weight: 83.66 kDa 
  • Atom Count: 5,282 
  • Modeled Residue Count: 650 
  • Deposited Residue Count: 736 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Kinesin-like protein KIF11
A, B
368Homo sapiensMutation(s): 0 
Gene Names: KIF11EG5KNSL1
UniProt & NIH Common Fund Data Resources
Find proteins for P52732 (Homo sapiens)
Explore P52732 
Go to UniProtKB:  P52732
PHAROS:  P52732
GTEx:  ENSG00000138160 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP52732
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
ADP

Query on ADP



Download:Ideal Coordinates CCD File
E [auth A],
H [auth B]
ADENOSINE-5'-DIPHOSPHATE
C10 H15 N5 O10 P2
XTWYTFMLZFPYCI-KQYNXXCUSA-N
3QC

Query on 3QC



Download:Ideal Coordinates CCD File
D [auth A],
G [auth B]
(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE
C20 H24 N2 O2
HPVCRUIDFODATB-LJQANCHMSA-N
MG

Query on MG



Download:Ideal Coordinates CCD File
C [auth A],
F [auth B]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
3QC BindingDB:  2FME IC50: 306 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.10 Å
  • R-Value Free:  0.305 (Depositor), 0.278 (DCC) 
  • R-Value Work:  0.280 (Depositor), 0.252 (DCC) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 159.8α = 90
b = 80β = 96.5
c = 69.2γ = 90
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
AMoREphasing
DMphasing
CNSrefinement
PDB_EXTRACTdata extraction
CNXrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

  • Released Date: 2006-04-18 
  • Deposition Author(s): Sheriff, S.

Revision History  (Full details and data files)

  • Version 1.0: 2006-04-18
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2017-10-18
    Changes: Refinement description
  • Version 1.4: 2024-02-14
    Changes: Data collection, Database references, Derived calculations
  • Version 1.5: 2024-04-03
    Changes: Refinement description